Inhibition of Cholera Toxin by Human Milk Fractions and Sialyllactose

The effects of human milk fractions on clolera toxin B subunit binding to monosialoganglioside 1 (G M1 ) were investigated. Human milk, human defatted milk, whey, and a low-molecular-weight fraction of human milk inhibited the binding, but casein did not inhibit it. The inhibitory activity of whey f...

Full description

Saved in:
Bibliographic Details
Published inBioscience, biotechnology, and biochemistry Vol. 59; no. 3; pp. 417 - 419
Main Authors Idota, Tadashi, Kawakami, Hiroshi, Murakami, Yuji, Sugawara, Makihiro
Format Journal Article
LanguageEnglish
Published Tokyo Taylor & Francis 1995
Japan Society for Bioscience Biotechnology and Agrochemistry
Oxford University Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The effects of human milk fractions on clolera toxin B subunit binding to monosialoganglioside 1 (G M1 ) were investigated. Human milk, human defatted milk, whey, and a low-molecular-weight fraction of human milk inhibited the binding, but casein did not inhibit it. The inhibitory activity of whey from bovine-milk-based infant formula was less than that of whey from human milk. Differences in composition between human and bovine whey seemed to influence the extent of the inhibitory activity. Sialylated oligosaccharides were considered to be the possible components that inhibited cholera toxin. The effects of sialyllactose, a predominant sialylated component of human milk, on cholera toxin-induced diarrhea were investigated by the rabbit intestinal loop method. Sialyllactose inhibited the cholera toxin inducing fluid accumulation, although neither sialic acid nor lactose had an effect on it. The results suggest that sialyllactose is responsible for the inhibitory activity of milk on cholera toxin.
ISSN:0916-8451
1347-6947
DOI:10.1271/bbb.59.417